Forte Cash from 2010 to 2024

FBRX Stock  USD 0.75  0.04  5.63%   
Forte Biosciences Cash yearly trend continues to be fairly stable with very little volatility. Cash will likely drop to about 11.4 M in 2024. Cash is the total amount of money in the form of currency that Forte Biosciences has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2017-03-31
Previous Quarter
21.1 M
Current Value
12 M
Quarterly Volatility
18.1 M
 
Covid
Check Forte Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Forte main balance sheet or income statement drivers, such as Interest Income of 1.3 M, Depreciation And Amortization of 8.6 K or Interest Expense of 14.5 K, as well as many exotic indicators such as Price To Sales Ratio of 9.98, Dividend Yield of 0.0 or PTB Ratio of 0.7. Forte financial statements analysis is a perfect complement when working with Forte Biosciences Valuation or Volatility modules.
  
This module can also supplement Forte Biosciences' financial leverage analysis and stock options assessment as well as various Forte Biosciences Technical models . Check out the analysis of Forte Biosciences Correlation against competitors.
For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.

Latest Forte Biosciences' Cash Growth Pattern

Below is the plot of the Cash of Forte Biosciences over the last few years. Cash refers to the most liquid asset of Forte Biosciences, which is listed under current asset account on Forte Biosciences balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Forte Biosciences customers. The amounts must be unrestricted with restricted cash listed in a different Forte Biosciences account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Forte Biosciences' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Forte Biosciences' overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

Forte Cash Regression Statistics

Arithmetic Mean20,221,849
Geometric Mean14,356,206
Coefficient Of Variation88.49
Mean Deviation15,672,768
Median8,150,000
Standard Deviation17,893,517
Sample Variance320.2T
Range53.3M
R-Value0.47
Mean Square Error267.5T
R-Squared0.22
Significance0.07
Slope1,894,315
Total Sum of Squares4482.5T

Forte Cash History

202411.4 M
202312 M
202241.1 M
202142 M
202058.8 M
20196.9 M
201840.8 M

Other Fundumenentals of Forte Biosciences

Forte Biosciences Cash component correlations

About Forte Biosciences Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Forte Biosciences income statement, its balance sheet, and the statement of cash flows. Forte Biosciences investors use historical funamental indicators, such as Forte Biosciences's Cash, to determine how well the company is positioned to perform in the future. Although Forte Biosciences investors may use each financial statement separately, they are all related. The changes in Forte Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Forte Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Forte Biosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Forte Biosciences. Please read more on our technical analysis and fundamental analysis pages.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Forte Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Forte Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Forte Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Forte Biosciences Stock:
Check out the analysis of Forte Biosciences Correlation against competitors.
For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Forte Stock analysis

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Is Forte Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Forte Biosciences. If investors know Forte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Forte Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.00)
Return On Assets
(0.50)
Return On Equity
(0.85)
The market value of Forte Biosciences is measured differently than its book value, which is the value of Forte that is recorded on the company's balance sheet. Investors also form their own opinion of Forte Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Forte Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Forte Biosciences' market value can be influenced by many factors that don't directly affect Forte Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Forte Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Forte Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Forte Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.